NPPA issued a notification regarding the fixation of the retail price of each hard gelatin capsule containing: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (as film-coated tablet form) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg

Dec 27, 2023 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on December 26, 2023, issued a notification regarding the fixation of the retail price of each hard gelatin capsule containing Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (as film-coated tablet form) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg.

The following has been stated: -

•The Retail Price (without local taxes) for each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (as film-coated tablet form) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg g (as film-coated tablet form) for M/s Pure Cure Healthcare Pvt Ltd (Manufacturer) & M/s Dr. Reddy’s Laboratories Ltd (Marketer) is Rs 19.21. 

The detailed notification is given in the document attached below.

[Notification No. 19(3743)/2023/DP/NPPA/Div.III/7161/2023]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT